215 related articles for article (PubMed ID: 4017416)
1. Isosorbide dinitrate bioavailability, kinetics, and metabolism.
Straehl P; Galeazzi RL
Clin Pharmacol Ther; 1985 Aug; 38(2):140-9. PubMed ID: 4017416
[TBL] [Abstract][Full Text] [Related]
2. Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing.
Straehl P; Galeazzi RL; Soliva M
Clin Pharmacol Ther; 1984 Oct; 36(4):485-92. PubMed ID: 6478734
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intravenous isosorbide-dinitrate.
Platzer R; Reutemann G; Galeazzi RL
J Pharmacokinet Biopharm; 1982 Dec; 10(6):575-86. PubMed ID: 7182455
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G
Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768
[TBL] [Abstract][Full Text] [Related]
5. Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual, and percutaneous dosing in angina.
Morrison RA; Wiegand UW; Jähnchen E; Höhmann D; Bechtold H; Meinertz T; Fung HL
Clin Pharmacol Ther; 1983 Jun; 33(6):747-56. PubMed ID: 6851405
[TBL] [Abstract][Full Text] [Related]
6. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.
Laufen H; Aumann M; Leitold M
Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933
[TBL] [Abstract][Full Text] [Related]
7. [Bioavailability of isosorbide dinitrate and isosorbide-5-mononitrate under steady-state conditions].
Rietbrock N; Knoll J; Merz PG; Menke G
Dtsch Med Wochenschr; 1985 Nov; 110(47):1821-5. PubMed ID: 3905327
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate.
Schaumann W
Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):445-53. PubMed ID: 2681004
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of isosorbide dinitrate.
Fung HL
Am Heart J; 1985 Jul; 110(1 Pt 2):213-6. PubMed ID: 4013997
[TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic model for isosorbidedinitrate, isosorbide-2-mononitrate, and isosorbide-5-mononitrate.
Smith D; Aldrich W; Dey M; Enever R; Warner R; Weierstall R
Drug Metab Dispos; 1990; 18(4):429-34. PubMed ID: 1976063
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of intravenous and oral isosorbide - 5 - mononitrate.
Abshagen U; Betzien G; Endele R; Kaufmann B
Eur J Clin Pharmacol; 1981; 20(4):269-75. PubMed ID: 7308280
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate].
Lutz VD; Gielsdorf W; Rasper J; Jaeger H; Loew D
Arzneimittelforschung; 1985; 35(4):730-4. PubMed ID: 4015739
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics of low-dose isosorbide dinitrate and metabolites after buccal or oral administration].
Keller-Stanislawski B; Marschner JP; Rietbrock N
Arzneimittelforschung; 1992 Jan; 42(1):17-20. PubMed ID: 1586374
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability and metabolism of isosorbide dinitrate from a transdermal spray.
Laufen H; Leitold M
Arzneimittelforschung; 1992 Jul; 42(7):931-5. PubMed ID: 1418058
[TBL] [Abstract][Full Text] [Related]
15. [Concentration-time profile of isosorbide dinitrate and its metabolites in plasma following percutaneous resorption of a transdermal therapeutic system].
Menke G; Schnellhammer R; Rietbrock N
Arzneimittelforschung; 1987 Nov; 37(11):1301-3. PubMed ID: 3440041
[TBL] [Abstract][Full Text] [Related]
16. Isosorbide dinitrate disposition in the rat: metabolite pharmacokinetics and interactions.
Morrison RA; Fung HL
J Pharmacol Exp Ther; 1984 Oct; 231(1):124-30. PubMed ID: 6491969
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of isosorbide dinitrate and its mononitrate metabolites after intravenous infusion.
Santoni Y; Iliadis A; Cano JP; Luccioni R; Frances Y
J Pharmacokinet Biopharm; 1986 Feb; 14(1):1-17. PubMed ID: 3746630
[TBL] [Abstract][Full Text] [Related]
18. Plasma isosorbide dinitrate concentrations in human subjects after administration of standard and sustained-release formulations.
Assinder DF; Chasseaud LF; Taylor T
J Pharm Sci; 1977 Jun; 66(6):775-8. PubMed ID: 577507
[TBL] [Abstract][Full Text] [Related]
19. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
Geigenberger A; Degen J; Maier-Lenz H
Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and haemodynamic effects of ISDN following different dosage forms and routes of administration.
Vogt D; Trenk D; Bonn R; Jähnchen E
Eur J Clin Pharmacol; 1994; 46(4):319-24. PubMed ID: 7957516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]